{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:10:02Z","timestamp":1746101402616,"version":"3.40.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.vaccine.2013.12.047","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T08:45:15Z","timestamp":1389084315000},"page":"924-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka"],"prefix":"10.1016","volume":"32","author":[{"given":"De Alwis","family":"K.N.L.S.K.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeysinghe","family":"M.R.N.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wickramesinghe","family":"A.R.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wijesinghe","family":"P.R.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.12.047_bib0005","series-title":"Vaccines","first-page":"671","article-title":"Japanese Encephalitis vaccines","author":"Tsai","year":"1994"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0010","series-title":"Doctor of medicine","article-title":"Aspects of the outbreak of Japanese Encephalitis in Anuradhapura district","author":"Abeysinghe","year":"1987"},{"issue":"17","key":"10.1016\/j.vaccine.2013.12.047_bib0015","first-page":"1","article-title":"Epidemiology and control of Japanese Encephalitis","volume":"93","author":"Epidemiology Unit","year":"1993","journal-title":"Weekly Epidemiological Report"},{"issue":"3","key":"10.1016\/j.vaccine.2013.12.047_bib0020","first-page":"17","article-title":"Surveillance report on Japanese Encephalitis\u20142007","volume":"49","author":"Epidemiology Unit","year":"2008","journal-title":"Epidemiological Bulletin (Sri Lanka)"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0025","unstructured":"Epidemiology Unit. Japanese Encephalitis: a manual for Medical Officers of Health. Colombo: Epidemiology Unit, \u3008http:\/\/www.epid.gov.lk\/web\/attachments\/article\/141\/JE%20book.pdf\u3009; [accessed 24 August, 2013]."},{"issue":"10","key":"10.1016\/j.vaccine.2013.12.047_bib0030","first-page":"1","article-title":"Adverse events following JE vaccine","volume":"32","author":"Epidemiology Unit","year":"2005","journal-title":"Weekly Epidemiological Report"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0035","series-title":"Proceedings of the 2nd meeting of the immunization stakeholders","article-title":"National Immunization Summit, Sri Lanka","author":"Epidemiology Unit","year":"2007"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0040","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.ijid.2008.05.132","article-title":"The landscape of new vaccines for Japanese Encephalitis: country-level strategies for introduction","volume":"12","author":"Abeysinghe","year":"2008","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0045","series-title":"Doctor of medicine","article-title":"To evaluate the effectiveness of the Japanese Encephalitis immunization programme","author":"DeAlwis","year":"2006"},{"year":"1991","series-title":"Sample size determination in health studies: a practical manual","author":"Lwanga","key":"10.1016\/j.vaccine.2013.12.047_bib0050"},{"year":"1987","series-title":"Epidemiology in medicine","author":"Hennekens","key":"10.1016\/j.vaccine.2013.12.047_bib0055"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0060","series-title":"Vaccines","first-page":"919","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2004"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0065","series-title":"User manual for the revised WHO classification","article-title":"Causality assessment of adverse event following immunization (AEFI)","author":"WHO","year":"2013"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0070","series-title":"Special volume 18-pediatric neurology","article-title":"Recent advances in paediatrics","author":"Gupte","year":"2008"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0075","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1034\/j.1398-9995.2001.056008804.x","article-title":"Inoyue","volume":"56","author":"Sakaguchi","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomised, double blind, placebo controlled, phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese Encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0085","first-page":"325","article-title":"WHO position paper on Japanese Encephalitis vaccines","volume":"81","author":"WHO","year":"2006","journal-title":"Weekly Epidemiological Record"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0090","first-page":"105","article-title":"Japanese encephalitis vaccines: current vaccines and future prospects","volume":"267","author":"Monath","year":"2002","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2013.12.047_bib0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0889-8561(03)00102-4","article-title":"Allergic reactions to Japanese Encephalitis vaccines","volume":"23","author":"Plesner","year":"2003","journal-title":"Immunology Allergy Clinics in North America"},{"issue":"11","key":"10.1016\/j.vaccine.2013.12.047_bib0100","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0264-410X(97)00020-0","article-title":"Allergic muco-cutaneous reactions to Japanese encephalitis vaccine","volume":"15","author":"Plesner","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.12.047_bib0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/14760584.2.3.407","article-title":"Japanese encephalitis vaccines: moving away from the mouse brain","volume":"2","author":"Zanin","year":"2003","journal-title":"Expert Review of Vaccines"},{"issue":"No. RR1","key":"10.1016\/j.vaccine.2013.12.047_bib0110","first-page":"8","article-title":"Inactivated Japanese Encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"42","author":"Centers for Disease Control","year":"1993","journal-title":"Morbidity and Mortality Weekly Return"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0115","series-title":"Vaccines","first-page":"672","article-title":"Japanese Encephalitis vaccines","author":"Tsai","year":"1999"},{"issue":"6","key":"10.1016\/j.vaccine.2013.12.047_bib0120","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2012.11.095","article-title":"Investigation of an outbreak of hypersensitivity-type reactions during the 2004 national measles\u2013mumps\u2013rubella vaccination campaign in Brazil","volume":"31","author":"Freitas","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2013.12.047_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3201\/eid0601.000103","article-title":"Japanese encephalitis immunization in South Korea: past, present and future","volume":"6","author":"Sohn","year":"2000","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.12.047_bib0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0163-4453(96)91281-5","article-title":"Adverse reactions to Japanese Encephalitis vaccine in German travellers","volume":"32","author":"Northdurft","year":"1996","journal-title":"Journal of Infection"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:30:00Z","timestamp":1746099000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13017908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0264410X13017908"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}